We investigated the effects of flow rate and dopamine on systemic oxygen delivery (DO 2 ), oxygen consumption (VO 2 ) and gastric mucosal microcirculatory blood flow (gMCF), measured by laser Doppler flowmetry in 12 patients undergoing mild hypothermic (34 ЊC) cardiopulmonary bypass (CPB). The first intervention comprised increasing CPB flow rates from 2.4 to 3.0 litre min 91 m
. Measurements were made before and 10 min after the start of one of the two interventions. The heart remained in cardioplegic arrest throughout the study. There were no significant differences in variables between the two baseline measurements preceding the interventions. The increase in CPB flow rate increased Do 2 and gMCF without affecting VO 2 At constant flow rate, dopamine also increased gMCF with no change in VO 2 , DO 2 or mean arterial pressure. Our data suggested that dopamine had no flow-independent effect on VO 2 We have shown previously that in patients undergoing cardiopulmonary bypass (CPB), dobutamine caused a flow-independent increase in oxygen consumption (VO2) without affecting gastric mucosal blood flow. 1 In common with dobutamine, dopamine increased VO2 in healthy volunteers with an intact circulation. 2 Unlike dobutamine, dopamine has been shown to increase splanchic 3 and gastric 3 mucosal blood flow in animals and humans. As gut mucosal ischaemia has been reported during cardiac surgery, and to correlate with postoperative morbidity, [5] [6] [7] administration of dopamine during cardiac surgery may be a means of ameliorating intraoperative splanchnic hypoperfusion in susceptible patients. However, the ability of dopamine to increase splanchnic blood flow has been challenged recently. 8 9 In pigs, dopamine did not increase total gastric blood flow during CPB. 8 However, dopamine may increase mucosal blood flow without affecting total gastric blood flow.
Therefore, the aims of this study were to investigate the effects of dopamine on VO2 and on gastric microcirculatory blood flow during constant flow CPB in patients undergoing cardiac surgery. We hypothesized that dopamine would be comparable with dobutamine in its flow-independent effects on VO2 but would differ in its effect on gastric microcirculatory blood flow. As we and others have shown, CPB provides a unique opportunity to study global and regional effects of drugs during constant flow. 1 10 11 
Patients and methods
After obtaining approval from the Ethics Committee of Essen University, and informed consent, we studied 12 patients requiring CPB for coronary artery bypass grafting. All patients received flunitrazepam 2 mg approximately 1 h before arriving in the operating room. Under local anaesthesia, a left radial arterial cannula and a flow-directed pulmonary artery catheter were inserted. Anaesthesia was induced with etomidate 0.15-0.30 mg kg 91 , pancuronium 0.1 mg kg 91 and fentanyl 5-7 g kg 91 , and maintained with 0.4-0.6 vol% isoflurance and 50% nitrous oxide in oxygen. Before CPB, additional fentanyl 0.25 mg, pancuronium 2 mg and flunitrazepam 0.2 mg were administered as needed. Fentanyl 0.25 mg and pancuronium 4 mg were added to the CPB prime, and 0.4 vol% isoflurane, added to the oxygenator air flow, was continued throughout the bypass period. Non-pulsatile pump flow (Stöckert, Munich, Germany) at a standard flow rate of 2.4 litre min 91 m 92 was maintained during extracorporeal circulation. Oxygenation was provided by a Cobe CML membrane oxygenator (Laboratories GmbH, Heimstetten, Germany). The asanguineous prime contained lactated Ringer's solution 100 ml, 10% hydroxyethylstarch 500 ml, 20% mannitol 100 ml and 8.4% sodium bicarbonate 100 ml. During CPB, blood temperature was maintained at 34 ЊC and packed cell volume was kept above 20% by transfusion of autologous packed red cells before bypass. Measurements were made after CPB had commenced, the aorta cross-clamped, the heart in cardioplegic arrest and after rectal and nasopharyngeal temperatures were within 0.8 ЊC of each other.
Gastric mucosal microcirculatory blood flow was studied using laser Doppler flowmetry (LDF) (MBF 3D, Moors Instruments Ltd, Devon, UK). The measurement probe, a fibreoptic wire, was inserted through the lumen of a nasogastric tube. The correct position of the nasogastric tube was confirmed by auscultation and aspiration of gastric contents. The correct position of the probe was verified by observing typical pulse synchronous oscillations. The frequency band used throughout the investigation was 14.9 kHz and the last 2 min of each period were averaged for the measurements. LDF uses the size and amount of the frequency shift caused by backscattered laser beam to calculate microcirculatory flow. 12 LDF has been used experimentally to measure intestinal mucosal blood flow, and has been found to correlate with mucosal blood flow, as measured by standard techniques. 13 In addition to gastric microcirculatory blood flow, skin microcirculatory blood flow was studied by placing a second probe on the forehead of the patient.
Initial measurements were made at a flow rate of 2. 4 , and measurements were repeated 5 min later (baseline 2). Subsequently, with no change in flow, dopamine was started at a rate of 6 g kg 91 min 91 (intervention 2), and repeat measurements were made 10 min later. At each of these times, blood samples were obtained from sampling ports of the CPB cannulae for measurement of blood-gas tensions, and electrolyte and glucose concentrations, and haemodynamic variables were recorded. Bloodgas tensions were measured immediately at 37 ЊC. Total body oxygen delivery (DO2) and VO2 were calculated according to standard formulae.
Non-parametric analysis of variance (Friedman) was used to test for differences between times. The Wilcoxon signed rank test, corrected for multiple comparisons (Bonferroni), was used to test for differences between each baseline and subsequent intervention, and between the two baseline values. Statistical significance was based on P : 0.05. Results are presented as mean (SD). The statistical program used was SPSS version 6.0 on an Accel (486DX33) Notebook computer (Accel Computers, Rockville, MD, USA).
Results
Patient data are summarized in 78 (8) 80 (8) 80 (9) 83 ( in DO2, VO2, sMCF or MAP during this intervention. Blood glucose concentrations increased throughout the study (P : 0.05) unrelated to the individual intervention. Potassium and haemoglobin concentrations, and body temperature did not change significantly (table 3) .
Discussion
The principal findings of this study were: (1) at constant flow, dopamine did not increase VO2; (2) at constant flow, dopamine increased gastric mucosal blood flow; and (3) increasing flow rates increased gastric mucosal blood flow.
Our finding that dopamine increased mucosal blood flow is consistent with previous studies. Dopamine receptors have been identified in the human gastric mucosa.
14 When injected locally into the gastric submucosa, dopamine increased gastric mucosal blood flow, as assessed by laser Doppler flowmetry. 4 Furthermore, in the rat, dopamine exhibited a protective role in the stomach. 15 Our study demonstrated that dopamine, administered i.v. at clinically relevant doses, may increase gastric microcirculatory blood flow in humans during CPB, supporting the role of dopaminergic receptors in regulating gastric mucosal blood flow in humans.
In contrast with the increases in gastric microcirculatory blood flow during both increase in flow and dopamine infusion, skin microcirculatory blood flow did not increase during each intervention. Differences in baseline vasomotor tone or vascular reactivity between gastric mucosal and cutaneous vasculature, or both, may explain the different regional flow responses. To what extent differences in flow response are caused by redistribution of flow between regional circulations on the basis of a steal phenomenon cannot be determined by this investigation.
In two previus studies using a similar design, we found that during constant flow CPB, chronic pretreatment with beta adrenoceptor antagonists decreased VO 2 10 and dobutamine increased VO 2 .
1 These findings suggest a flow-independent effect of catecholamines on VO 2 during CPB. In contrast with our previous findings with dobutamine, dopamine did not increase VO 2 during constant flow CPB. Whereas dobutamine 5-10 g kg 91 min 91 increased VO 2 or energy expenditure in normal volunteers by 22-30%, 16 17 comparable doses of dopamine increased VO 2 or energy expenditure by only 6-10%. 2 18 19 Thus dopamine appears to increase VO 2 to a lesser extent than dobutamine. In these studies, both dopamine and dobutamine increased heart rate, stroke volume, cardiac output and, most likely, myocardial oxygen consumption. When the heart is in cardioplegic arrest and unable to respond mechanically to catecholamine stimulations (as in this study), catecholamines are likely to produce a smaller increase in VO 2 . In accordance with this hypothesis, dobutamine, administered in comparable doses, caused a 22-33% increase in VO 2 in healthy volunteers 2 19 but only an 11% increase during CPB. 1 Conversely, the small 6-10% increase in VO 2 during administration of dopamine in the presence of an intact circulation 2 19 would explain the lack of an increase in VO 2 during constant flow CPB in this study.
However, our results may only apply to nonpulsatile flow conditions. In the presence of pulsatile flow the absolute and relative effects of dopamine on gastric and cutaneous microcirculations may differ.
Increasing flow rate increased gastric microcirculatory blood flow. As VO 2 did not increase during this intervention, hypoperfusion is unlikely to have occurred at the lower flow rate. Although increasing flow rates may increase the likelihood of damage to blood components, our findings suggest that increasing flow rates may be a means of increasing gastric microcirculatory blood flow in patients at risk of splanchnic hypoperfusion.
Laser Doppler flowmetry has been used previously to measure mucosal microcirculatory blood flow in animals 20 and humans. 13 Whereas in the absence of CPB, mechanical heart activity and ventilatory excursions transmitted to the very sensitive measurement probe via the oesophagus do, at times, produce artefacts, with the heart in cardioplegic arrest during CPB such artefacts do not occur. Laser Doppler flowmetry may not be reliable when there are acute changes in haemoglobin concentration. 20 However, haemoglobin concentration did not change through our study.
Randomization of the sequence of interventions (i.e. flow variation and dopamine infusion) might have been preferable. However, as there are no data on the clearance of dopamine during hypothermia we chose not to randomize the sequence of interventions. The similar values before flow intervention and before dopamine infusion are evidence of stability, and of return to baseline conditions after flow intervention. In addition, in three patients in whom the duration of CPB allowed a repeat measurement 10 min after discontinuation of infusion of dopamine, the laser signal returned to near baseline values.
In conclusion, our data suggest that both increasing CPB flow rates and infusing dopamine during constant flow CPB did not affect VO 2 but increased gastric microcirculatory blood flow. Patients at risk of gastric mucosal ischaemia may thus benefit from dopamine during CPB.
